首页> 美国卫生研究院文献>Journal of Clinical and Translational Research >Legal challenges for the implementation of advanced clinical digital decision support systems in Europe
【2h】

Legal challenges for the implementation of advanced clinical digital decision support systems in Europe

机译:在欧洲实施高级临床数字决策支持系统的法律挑战

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Systems based on artificial intelligence and machine learning that facilitate decision making in health care are promising new tools in the era of ‘personalized’ or ‘precision’ medicine. As the volume of patient data and scientific evidence grows, these computerised decision support systems (DSS) have great potential to help healthcare professionals improve diagnosis and care for individual patients. However, the implementation of these tools in clinical care raises some foreseeable legal challenges for healthcare providers and DSS-suppliers in Europe: How does the use of complex and novel DSS relate to professional standards to provide a reasonable standard of care? What should be done in terms of testing before DSS can be used in regular practice? What are the potential liabilities of health care providers and DSS companies if a DSS fails to function well? How do legal requirements for the protection of patient data and general privacy rights apply to likely DSS scenarios? In this article, we provide an overview of the current law and its general implications for the use of DSS, from a European perspective. We conclude that healthcare providers and DSS-suppliers will have the best chance of meeting legal challenges if: they are first tested in translational research with the patients’ explicit, informed consent; DSS-suppliers and healthcare providers are able to clarify and agree on their individual legal responsibilities, and; patients are properly informed about privacy risks and able to decide themselves whether their data can be used for other purposes, or are stored and processed outside the EU. DSS developers and healthcare providers will need to work together closely to ensure compliance with national and European regulations and standards required for reasonable and safe patient care.Relevance for patientsAdvanced digital decision support systems have the potential to improve patient diagnosis and care. In this article we discuss key legal issues to support translational research using DSS and ensure that they meet the high standards for protection of patient safety and privacy in Europe.
机译:在“个性化”或“精密”医学时代,基于人工智能和机器学习的系统有助于医疗保健决策,这些系统有望成为新工具。随着患者数据和科学证据数量的增长,这些计算机决策支持系统(DSS)具有巨大的潜力,可以帮助医疗保健专业人员改善对单个患者的诊断和护理。但是,这些工具在临床护理中的实施对欧洲的医疗保健提供者和DSS供应商提出了一些可预见的法律挑战:复杂而新颖的DSS的使用如何与专业标准相关联以提供合理的护理标准?在常规实践中使用DSS之前,应该在测试方面做什么?如果DSS无法正常运作,医疗保健提供者和DSS公司的潜在责任是什么?保护患者数据和一般隐私权的法律要求如何适用于可能的DSS方案?在本文中,我们从欧洲的角度概述了现行法律及其对使用DSS的一般含义。我们得出的结论是,医疗保健提供者和DSS供应商在以下情况下将有最好的机会应对法律挑战:他们首先在患者的明确知情同意下进行转化研究测试; DSS供应商和医疗保健提供者能够澄清并同意其各自的法律责任,并且;患者会被适当告知有关隐私风险,并能够自行决定他们的数据是否可用于其他目的,还是在欧盟以外存储和处理。 DSS开发人员和医疗保健提供者将需要紧密合作,以确保符合合理和安全的患者护理所需的国家和欧洲法规和标准。患者的相关性先进的数字决策支持系统有可能改善患者的诊断和护理。在本文中,我们讨论了支持使用DSS进行翻译研究的关键法律问题,并确保它们符合欧洲保护患者安全和隐私的高标准。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号